2020

1. Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

   Breast Cancer Research and Treatment, Vol. 180, Núm. 3, pp. 597-609